ScandiBio Featured on Life Science Sweden’s 2026 Phase III Watchlist
Sweden’s life science sector is entering a decisive phase. A recent overview from Life Science Sweden highlights that a growing number of Swedish life science companies…
-
-
The results of a phase II and III clinical trials about the treatment of COVID-19 patients with CMAs have been published at Advanced Science
The results of a Phase II and III studies have been published in the journal Advanced Science. COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities,…
-
The results of a phase I study of CMCS have been published
The results of a Phase I study have been published in the journal Molecular Systems Biology describing the kinetics of the Combined Metabolic Cofactor Supplementation (CMCS)…
-
An article has been published how to address the heterogeneity in liver diseases with AI-based genome metabolic modeling
An article has been published in Briefings in Bioinformatics about the heterogeneity in liver diseases. The abnormalities in human metabolism have been implicated in the progression…
-
A review article has been published discussing the current status of COVID-19 therapies
A review paper has been published in the journal iScience about the use of drug repositioning applications in treatment of COVID-19 patients. The rapid and global…
-
A review article has been published regarding the host-microbiome interactions in neurodegenerative diseases
A review paper has been published in the journal Frontiers in Neuroscience discussing the use of AI-based systems biology approaches to understand the Host–Microbiome Interactions in…
-
A review article has been published about the use of AI-based systems biology for drug development to treat neurodegenerative diseases
A review paper has been published in the journal Drug Discovery Today discussing the use of systems biology approaches for studying neurodegenerative diseases including Alzheimer’s Disease…
